The global choline bitartrate market accounted for US$ 406Mn in 2021 and is expected to reach US$ 694 Mn by 2030 with a considerable CAGR of 6.2% during the forecast timeframe of 2022 to 2030.
The global market for choline bitartrate is expected to witness considerable growth in the near future, owing to the increased physiological importance of choline metabolites in the maintenance of good health. Choline bitartrate is a combination of choline and a tartaric acid salt. It has a much higher absorption rate than natural choline, which is an inherent human nutrient. Although choline is chemically related to the B vitamins, it is officially recognized as an essential nutrient by the Food and Nutrition Board of the Institute of Medicine in the US in 1998. Supplementing with choline bitartrate can help with absentmindedness and memory recall. Because choline tends to help nerves interact with muscles, it is also being used to study its ability to sustain neuromuscular function as human’s age. Additionally, choline bitartrate is being used to treat, prevent, control, and improve diseases and conditions such as liver disease, memory loss, depression, Alzheimer's disease, Huntington's chorea, Dementia, Tourette's, seizures, cerebellar ataxia, schizophrenia, and others.
Drivers
· Growing pharmaceutical industry along with the presence of a strong manufacturing capacity
· Growing demands for infant formula
· High demand for nutritional food & beverages
Restraints
· Growing consumer tendency towards natural ingredients
· Increasing raw material prices
Opportunities
· Increasing awareness regarding good nutrients and increasing focus on preventive health care
· Increasing incidence of chronic conditions
Report Coverage
| Market | Choline Bitartrate Market |
| Market Size 2021 | US$ 406 Mn |
| Market Forecast 2030 | US$ 694 Mn |
| CAGR | 6.2 % During 2021 - 2028 |
| Analysis Period | 2018 - 2030 |
| Base Year | 2021 |
| Forecast Data | 2021 - 2028 |
| Segments Covered | By Type, By Application And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Balchem Inc, Cepham Life Sciences, Aurora Fine Chemicals LLC, Salvi Chemical Industries Ltd, Alfa Aesar, AK Scientific Inc., Arochem Industries, Jinan Pengbo Biotechnology Co., Ltd., Finetech Industry Limited, NutriScience Innovations, LLC, Glentham Life Sciences Limited, and TCI Chemicals (India) Pvt. Ltd. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
| Customization Scope |
10 hrs of free customization and expert consultation |
Choline Bitartrate Market Dynamics
Global consumption of choline bitartrate is increasing due to rising consumer health consciousness. Furthermore, prominent industry participants are increasing their investment and R&D activities to develop cost-effective, high-quality choline bitartrate products with negligible toxic effects, which is driving the market growth. In addition, demand for choline bitartrate is expected to rise as the use of infant formula has increased over the last few decades.
Choline bitartrate is used in the medical field to treat a variety of conditions and diseases, as well as as a nutritional supplement. Livestock and animal feed also contain choline bitartrate. As a result, new and existing choline bitartrate manufacturers could focus on producing choline bitartrate for farm animals and livestock feed, as there is a promising demand for feed ingredients in this sector. In addition, the growing baby food and dietary supplement markets are expected to drive choline bitartrate growth in the forthcoming years. Based on the aforementioned factors, the choline bitartrate industry is expected to grow positively during the projected timeframe. Besides that, rising raw material costs are expected to stymie global market growth in the coming years.
Market Segmentation
Market by Type
· DL-Type
· L-Type
· D-Type
In terms of type, DL choline bitartrate will have a sizable market share in 2021. The composition of choline DL-tartaric acid produces DL-type choline bitartrate. It is mostly used in the manufacture of dietary supplements. With the proper dosage of DL choline bitartrate, it aids in the prevention and treatment of specific mental health problems. However, the benefits of DL choline bitartrate include increased muscle strength in athletes as well as muscle building, weight loss, liver support, heart conditions, and memory problems. Supplements containing DL-Type choline bitartrate aid in the treatment of choline deficiency, which causes liver disease and muscle damage. Additionally, choline DL-bitartrate, a choline substance is currently available in powder, gelatin, capsules, and vegetarian capsules.
Market by Application
· Pharmaceutical & Nutritional Supplement
· Baby Food
· Food & Beverage
· Others
In terms of application, the baby food segment is expected to hold the largest share of the choline bitartrate industry in 2021. Choline bitartrate is an essential nutrient in the vitamin B family. It is a nutrient found in human milk that is necessary for the development of fetuses and infants. It is required for the structure and function of all cells in the body, and it is especially important during periods of rapid growth and development in newborn babies, such as brain development. Furthermore, choline bitartrate plays an important role in cognitive development, and studies have shown that it can positively affect infant memory. Thus, for infants and toddlers, choline bitartrate is still required. Throughout that period of rapid growth, choline bitartrate is used to promote the development of the nervous system and memory formation. However, breastfeeding women should take antenatal and postnatal supplements to meet the nutritional needs of their newborns.
Choline Bitartrate Market Regional Overview
North America
· U.S.
· Canada
Europe
· U.K.
· France
· Germany
· Spain
· Rest of Europe
Latin America
· Mexico
· Brazil
· Rest of Latin America
Asia-Pacific
· India
· China
· Japan
· Australia
· South Korea
· Rest of Asia-Pacific
Middle East & Africa
· South Africa
· GCC
· Rest of Middle East & Africa
The North America region is expected to grow with a significant share of the choline bitartrate market during the forecasted timeframe. Because of its healthy lifestyle, geriatric population, increasing disposable income, and rising chronic conditions, this growth is expected to be the largest consumer of nutritional supplements. According to the research studies, more than 75% of adults in the United States use a nutritional supplement. Owing to the fact that North America has a well-developed supplement industry and is a producer of choline bitartrate at reasonable prices that are distributed globally. Furthermore, the region's growth has been aided by the presence of a large number of pharmaceutical and nutraceutical companies. Changing lifestyles as a result of hectic and stressful living has increased the demand for packaged foods and beverages in the region. Packaged foods and drinks are commonly accessible, cost-effective, and convenient to consume; as a result, their popularity among North America's young population is rapidly increasing; this aspect is also beneficial to regional market expansion.
Competitive Landscape
Some of the prominent players in global choline bitartratemarket are Balchem Inc, Cepham Life Sciences, Aurora Fine Chemicals LLC, Salvi Chemical Industries Ltd, Alfa Aesar, AK Scientific Inc., Arochem Industries, Jinan Pengbo Biotechnology Co., Ltd., Finetech Industry Limited, NutriScience Innovations, LLC, Glentham Life Sciences Limited, and TCI Chemicals (India) Pvt. Ltd.
Frequently Asked Questions
How much was the estimated value of the global choline bitartrate market in 2021?
The estimated value of global choline bitartrate market in 2021 was accounted to be US$406Mn.
What will be the projected CAGR for global choline bitartrate market during forecast period of 2022 to 2030?
The projected CAGR of choline bitartrate during the analysis period of 2022 to 2030 is 6.2%.
Which are the prominent competitors operating in the market?
The prominent players of the global choline bitartrate market involve Balchem Inc, Cepham Life Sciences, Aurora Fine Chemicals LLC, Salvi Chemical Industries Ltd, Alfa Aesar, AK Scientific Inc., Arochem Industries, Jinan Pengbo Biotechnology Co., Ltd., Finetech Industry Limited, NutriScience Innovations, LLC, Glentham Life Sciences Limited, and TCI Chemicals (India) Pvt. Ltd.
Which region held the dominating position in the global choline bitartrate market?
Asia-Pacificheld the dominating share for choline bitartrate during the analysis period of 2022 to 2030
Which region exhibited the fastest growing CAGR for the forecast period of 2022 to 2030?
North America region exhibited fastest growing CAGR for choline bitartrate during the analysis period of 2022 to 2030
What are the current trends and dynamics in the global choline bitartrate market?
The growing pharmaceutical industry along with the presence of a strong manufacturing capacity, increasing demands for infant formula and nutritional food & beverages are the prominent factors that fuel the growth of global choline bitartrate market
By segment application, which sub-segment held the maximum share?
Based on application, baby food segment held the maximum share for choline bitartrate market in 2021
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
